Som det forventes for stoffer, hvor den renale udskillelse kun står for 30% af den totale plasmaudskillelse, er der ikke set korrelation mellem nyrefunktion og valsartans systemiske eksponering.
As expected for a compound where renal clearance accounts for only 30% of total plasma clearance, no correlation was seen between renal function and systemic exposure to valsartan.